Academic Health Center
Stay Connected
news-and-notes

U joins national partnership aimed at expanding biopharmaceutical workforce and industry

The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a public-private partnership supported by a $70M investment from the National Institute of Standards and Technology and at least $129M from other participants, aims to transform biopharmaceutical manufacturing in the U.S.

Read more
research-and-clinical-trials

UMN doctor researches new way to treat spinal cord injuries

In today’s medical technology world, there are no effective therapies for spinal cord injuries.

Ann Parr, M.D., Ph.D., an assistant professor in the Department of Neurosurgery at the Medical School, is working with Michael McAlpine, Ph.D., and being assisted by James Dutton, Ph.D. at the Stem Cell Institute, to lead a new research project using 3D printing to create a scaffold, which can then be used to treat spinal cord injuries.

Read more
research-and-clinical-trials

Regenerative medicine funding approved, benefits MN researchers, residents

The 2014 Minnesota legislative session brought a big win for regenerative medicine, as legislators passed a bill allotting nearly $50 million over 10 years for research. Governor Dayton signed the measure in late May.

Leading the charge was Representative Erin Murphy in the House and Senator Katie Sieben in the Senate. The work was supported by both the University of Minnesota Stem Cell Institute (SCI) and Mayo Clinic Center for Regenerative Medicine.

HealthTalk spoke with the SCI director and Masonic Cancer Center researcher, Jakub Tolar, M.D., Ph.D., to get more details on the funding, regenerative medicine, and what this means for Minnesota.

Read more